Cambridge Healthtech Institute’s Third AnnualClinical NGS Assays
|
||
View Preliminary Agenda Molecular diagnostics, particularly next-generation sequencing (NGS), have become an integral component of disease diagnosis. Still, there is work to be done to establish these tools as the standard of care. The Third Annual Clinical NGS Assays event will address NGS assay validation, establishing NGS standards, and determining clinical relevance. The pros and cons of various techniques such as gene panels, whole exome, and whole genome sequencing will also be debated with regards to depth of coverage, clinical utility, and reimbursement. Overall, this event will address the needs of both researchers and clinicians while exploring strategies to increase collaboration for improved patient outcomes. Special Early Registration Savings Available Preliminary Agenda ASSAY VALIDATION AND ANALYSIS Best Practices for Using Genome in a Bottle Reference Materials to Benchmark Variant Calls NGS in Clinical Diagnosis: Aspects of Quality Management Thorough Validation and Implementation of Preimplantation Genetic Screening for Aneuploidy by NGS EXOME INTERPRETATION CHALLENGES Are We There Yet? The Odyssey of Exome Analysis and Interpretation Challenges in Exome Interpretation: Intronic Variants Exome Sequencing: Case Studies of Diagnostic and Ethical Challenges ESTABLISHING STANDARDS Implementing Analytical and Process Standards Assuring the Quality of Next-Generation Sequencing in Clinical Laboratory Practice Sponsored Presentation to be Announced by Genection PANEL DISCUSSION: GENE PANEL VS. WHOLE EXOME VS. WHOLE GENOME Panelists: DETERMINING CLINICAL SIGNIFICANCE AND RETURNING RESULTS Utility of Implementing Clinical NGS Assays as Standard-of-Care in Oncology An NGS Inter-Laboratory Study to Assess Performance and QC – Sponsored by Seracare This conference is part of the Eighth Annual Next-Generation Dx Summit.
|
Cambridge Healthtech Institute’s Third Annual Clinical NGS Assays; August 23-24, 2016 Washington DC
March 14, 2016 by sjwilliamspa
Posted in Clinical Diagnostics, Clinical Genomics, Genome Biology | Tagged clinical genomics, genetic testing, next generation sequencing, NGS, oncology | Leave a Comment
-
Recent Posts
- Linking Thrombotic Thrombocytopenia to ChAdOx1 nCov-19 Vaccination, AstraZeneca April 12, 2021
- Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure. April 10, 2021
- Embryogenesis in Mechanical Womb April 8, 2021
- COVID-19 Sequel: Neurological Impact of Social isolation been linked to poorer physical and mental health March 30, 2021
- T cells recognize recent SARS-CoV-2 variants March 30, 2021
- Top Industrialization Challenges of Gene Therapy Manufacturing March 29, 2021
- COVID-related financial losses at Mass General Brigham March 28, 2021
- Consuming a higher amount of unprocessed red meat or poultry is associated with a lower risk of iron deficiency anemia: Outcome-wide analyses in 475,000 men and women in the UK Biobank study March 27, 2021
- The WHO team is expected to soon publish a 300-page final report on its investigation, after scrapping plans for an interim report on the origins of SARS-CoV-2 — the new coronavirus responsible for killing 2.7 million people globally March 27, 2021
- Protected: How to position LPBI for a Sale – Joel’s Conversation with Aditya Bahl, 3/23/2021 March 24, 2021
Archives
Categories
Meta
-
2012pharmaceutical
-
Amandeep Kaur
-
Aashir Awan, Phd
-
Adina Hazan
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Daniel Menzin
-
Dror Nir
-
dsmolyar
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jayzmit48
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
Madison Davis
-
marzankhan
-
megbaker58
-
ofermar2020
-
Dr. Pati
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Leave a Reply